HtmlToText
search for: home pain relief contact menu ambien on november 1, 2018 0 comments - preparations for pain relief what is ambien? ambien belongs to the class of sedative / hypnotic drugs. ambien affects unbalanced brain chemicals that can cause insomnia. ambien has a sedative and relaxing effect. it is used to treat problems with sleep, such as the inability to fall asleep, frequent waking during the night, early morning waking. ambien is intended only for short-term use – as a rule, no more than 7-10 days. long-term use of the drug is permissible only under medical supervision. ambien may be used for other purposes not described in this manual. what should i discuss with a doctor before recepting ambien? before taking the drug, tell your doctor if you have; kidney disease; liver disease; alcohol or drug addiction; asthma, bronchitis, emphysema, or any other respiratory disease; depression or thoughts of suicide. if you suffer from one or more of the diseases listed above, you will not be able to take alprazolam, or you will need special dosing of the drug and constant monitoring during its use. ambien is categorized as b by the fda classification for pregnancy. this means that the harmful effects of the drug on the fetus is unlikely. do not take ambien if you are pregnant or may become pregnant during the course of taking the drug, without first consulting with your doctor. ambien enters the breast milk and can thus affect the baby. if you are a nursing mother, do not take the ambien without consulting a doctor. if you are over 60 years old, the likelihood of side effects of the drug is very high. you may need a reduced dose of ambien. according to the fda (us food and drug administration), ambien is not recommended for people under 18 years of age. applications ambien should be used exactly as recommended by your doctor. to clarify the instructions for use, consult your doctor or pharmacist. take each dose with a full glass of water. ambien is taken immediately before bedtime. you will be drowsy, you can fall and hurt yourself if you are not ready to go to bed. take the ambien only if you are waiting for a full night’s sleep before the next activity. do not exceed the prescribed dosage. you should not abruptly stop taking ambien if you have taken it for more than 1 or 2 weeks. there may be a withdrawal effect and cause a feeling of discomfort. if you need to stop taking the drug, consult your doctor. store ambien at room temperature in a cool, dry place. what will happen if i miss a preparation? since the ambien is designed to get rid of insomnia, in case of missing a drug, there will be no problems. the missed dose should be taken only if you guarantee 7-8 hours of good sleep after taking the drug. if you sleep for less than 7-8 hours, you may feel the “transfer effect” after waking up. what will happen in the case of overdose of the drug? seek medical attention immediately. overdose symptoms include drowsiness, confusion, dizziness, shortness of breath, and unconsciousness. precautionary measures the need to take precautions when driving, operating industrial equipment or performing other hazardous work. ambien causes drowsiness, possibly dizziness. in case of drowsiness or dizziness, you should refrain from dangerous activities. ambien must be taken immediately before bedtime. the next day, perhaps the feeling of “transfer effect”. when taking ambien should refrain from alcohol. alcohol in combination with ambien increases drowsiness and dizziness, which can be dangerous. do not take other sedatives, insomnia pills and tranquilizers, including those that are sold over-the-counter. you should refrain from such preparations, unless otherwise recommended by a doctor. tramadol on october 31, 2018 0 comments - preparations for pain relief characteristics of the substance tramadol tramadol hydrochloride is a white crystalline powder, odorless, bitter taste, soluble in water and ethanol. pharmacology pharmacological action – analgesic (opioid). activates opiate receptors (mu, delta and kappa) on the pre- and postsynaptic membranes of the afferent fibers of the nociceptive system, in the brain and spinal cord, as well as in the gastrointestinal tract; promotes the discovery of potassium and calcium channels, causes hyperpolarization of the membranes and inhibits the conduction of nerve impulses. it slows down the destruction of catecholamines and stabilizes their content in the central nervous system. the analgesic effect is due to a decrease in the activity of nociceptive and an increase in the antinociceptive systems of the body. inhibits the cerebral cortex, has a sedative effect, inhibits the cough and respiratory centers, stimulates the starting zone of the vomiting center, the nucleus of the oculomotor nerve; causes spasm of sphincter smooth muscles. after ingestion, it is quickly and completely absorbed (90%), absolute bioavailability – 68%, tmax – 2 hours. plasma protein binding – 20%. the volume of distribution depends on the method of administration and is 306 and 203 liters after oral or intravenous administration, respectively. passes through the bbb and other histohematogenous barriers, including the placental, is secreted into breast milk. biotransformation is carried out in the liver with the participation of cyp2d6 and cyp3a4 isoenzymes, mainly by n- and o-demethylation with subsequent conjugation. identified 11 metabolites, one of them – mono-o-dezmetiltramadol (m1) – has pharmacological activity. excreted mainly by the kidneys (90%, of which about 30% – unchanged) and the intestine (about 10%). in violation of the functions of the liver and kidneys (cl creatinine less than 80 ml / min), elimination slows down. use of the substance tramadol pain syndrome of medium and strong intensity (including with malignant neoplasms, injuries, in the postoperative period). pain relief during painful diagnostic or therapeutic interventions. contraindications hypersensitivity; conditions accompanied by respiratory depression or marked depression of the central nervous system (alcohol poisoning, sleeping drugs, narcotic analgesics, and other psychoactive drugs); risk of suicide, addiction to substance abuse, simultaneous administration of mao inhibitors (and a period of 2 weeks after their withdrawal), severe hepatic and / or renal failure, pregnancy (i term), breastfeeding (in the case of long-term use), children up to 1 year (for parenteral administration) and up to 14 years (for oral administration). restrictions on the use of opioid addiction, impaired consciousness of various origins, increased intracranial pressure, tbi, epilepsy, abdominal pain of unknown origin (acute abdomen), impaired renal function and / or liver. use during pregnancy and lactation appointment of tramadol is possible during pregnancy (ii and iii trimester) only under strict medical supervision, if the benefits to the mother outweigh the risk to the fetus. side effects of the substance tramadol from the nervous system and sensory organs: increased sweating, dizziness, headache, weakness, fatigue, lethargy, paradoxical stimulation of the central nervous system (nervousness, agitation, anxiety, tremor, muscle spasm, euphoria, emotional lability, hallucinations), drowsiness, sleep disorders , confusion of consciousness, impaired coordination of movements, instability of gait, convulsions of central genesis (with intravenous administration in high doses or with simultaneous prescription of antipsychotic drugs (neuroleptics), depression, amnesia, cognitive impairment, paresthesia, impaired vision, taste. on the part of the digestive tract organs: dry mouth, nausea, vomiting, flatulence, abdominal pain, constipation / diarrhea, difficulty in swallowing. since the cardiovascular system and blood (blood, hemostasis): tachycardia, orthostatic hypotension, syncope, collapse. from the genitourinary system: difficulty urinating, dysuria, urinary retention, menstrual disorders allergic rea
Informations Whois
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: ENTRAIDE-BIOMEDICALE.ORG
Registry Domain ID: D402200000003266924-LROR
Registrar WHOIS Server: whois.discount-domain.com
Registrar URL: www.onamae.com
Updated Date: 2017-08-25T08:44:06Z
Creation Date: 2017-08-09T14:34:15Z
Registry Expiry Date: 2018-08-09T14:34:15Z
Registrar Registration Expiration Date:
Registrar: GMO Internet, Inc. d/b/a Onamae.com
Registrar IANA ID: 49
Registrar Abuse Contact Email: abuse@gmo.jp
Registrar Abuse Contact Phone: +81.337709199
Reseller:
Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited
Registry Registrant ID: C195871025-LROR
Registrant Name: Kenji Hiraiwa
Registrant Organization: GMO DigiRock, Inc.
Registrant Street: 3-1 Ofuka-cho
Registrant Street: Grand Front Osaka Tower B 23F
Registrant City: Osaka-shi Kita-ku
Registrant State/Province: Osaka
Registrant Postal Code: 530-0011
Registrant Country: JP
Registrant Phone: +81.676342727
Registrant Phone Ext:
Registrant Fax: +81.663740121
Registrant Fax Ext:
Registrant Email: onamae@value-domain.com
Registry Admin ID: C195871026-LROR
Admin Name: Kenji Hiraiwa
Admin Organization: GMO DigiRock, Inc.
Admin Street: 3-1 Ofuka-cho
Admin Street: Grand Front Osaka Tower B 23F
Admin City: Osaka-shi Kita-ku
Admin State/Province: Osaka
Admin Postal Code: 530-0011
Admin Country: JP
Admin Phone: +81.676342727
Admin Phone Ext:
Admin Fax: +81.663740121
Admin Fax Ext:
Admin Email: onamae@value-domain.com
Registry Tech ID: C195871027-LROR
Tech Name: Kenji Hiraiwa
Tech Organization: GMO DigiRock, Inc.
Tech Street: 3-1 Ofuka-cho
Tech Street: Grand Front Osaka Tower B 23F
Tech City: Osaka-shi Kita-ku
Tech State/Province: Osaka
Tech Postal Code: 530-0011
Tech Country: JP
Tech Phone: +81.676342727
Tech Phone Ext:
Tech Fax: +81.663740121
Tech Fax Ext:
Tech Email: onamae@value-domain.com
Name Server: NS1.MD-OM-IQSV.COM
Name Server: NS2.MD-OM-IQSV.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2017-09-04T15:07:23Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to: (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.
REFERRER http://www.pir.org/
REGISTRAR Public Interest Registry
SERVERS
SERVER org.whois-servers.net
ARGS entraide-biomedicale.org
PORT 43
TYPE domain
RegrInfo
DOMAIN
NAME entraide-biomedicale.org
HANDLE D402200000003266924-LROR
CREATED 2017-09-08
STATUS
serverTransferProhibited https://icann.org/epp#serverTransferProhibited
NSERVER
NS1.MD-OM-IQSV.COM 52.69.230.86
NS2.MD-OM-IQSV.COM 52.69.233.143
OWNER
HANDLE C195871025-LROR
NAME Kenji Hiraiwa
ORGANIZATION GMO DigiRock, Inc.
ADDRESS
STREET
3-1 Ofuka-cho
Grand Front Osaka Tower B 23F
CITY Osaka-shi Kita-ku
STATE Osaka
PCODE 530-0011
COUNTRY JP
PHONE +81.676342727
EMAIL onamae@value-domain.com
ADMIN
HANDLE C195871026-LROR
NAME Kenji Hiraiwa
ORGANIZATION GMO DigiRock, Inc.
ADDRESS
STREET
3-1 Ofuka-cho
Grand Front Osaka Tower B 23F
CITY Osaka-shi Kita-ku
STATE Osaka
PCODE 530-0011
COUNTRY JP
PHONE +81.676342727
EMAIL onamae@value-domain.com
TECH
HANDLE C195871027-LROR
NAME Kenji Hiraiwa
ORGANIZATION GMO DigiRock, Inc.
ADDRESS
STREET
3-1 Ofuka-cho
Grand Front Osaka Tower B 23F
CITY Osaka-shi Kita-ku
STATE Osaka
PCODE 530-0011
COUNTRY JP
PHONE +81.676342727
EMAIL onamae@value-domain.com
REGISTERED yes
Go to top
entraide-biomedicale.org rapport :
Visitez le site